Skip to main content

Table 2 HLA Typing Results from Patients 1 and 2

From: Neurologic immune-related adverse events associated with adjuvant ipilimumab: report of two cases

HLA Class I

A

B

Bw

C

Cw

   

Patient 1

24:XX

07:XX

06:XX

04:XX

04:XX

   

29:XX

35:XX

06:XX

07:XX

07:XX

   

Patient 2

11:01

27:05

04:XX

01:02

    

24:02

35:01

06:XX

04:01

    

HLA Class II

DRB1

DRB3

DRB4

DRB5

DQB1

DQA1

DPB1

DRw

Patient 1

04:XX

 

01:XX

01:XX

03:XX

  

53:XX

15:XX

   

05:XX

  

51:XX

Patient 2

01:01

 

01:03

 

03:02

01:01

03:01

 

04:04

 

53:XX

 

05:01

03:01

14:01